United States· US:15054-0530_44512f6b-6a35-4db5-ba17-fe2fe3ec5170
Dysport
A medicinal product containing botulinum toxin type a, registered in United States by Ipsen Biopharmaceuticals, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BOTULINUM TOXIN TYPE A
- Manufacturer
- Ipsen Biopharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1115054053061 VIAL in 1 CARTON (15054-0530-6) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL
- ndc1115054-0530-6
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Botulinum toxin type a in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAlluzienceIpsen Pharma
- SwitzerlandAlluzience, InjektionslösungIPSEN Pharma Schweiz GmbH
- CzechiaALLUZIENCEIPSEN PHARMA S.A.S., Paříž
- PolandAlluzienceIpsen Pharma
- BelgiumAlluzience 200 Speywood-Eenheden/mlIpsen Pharma
- SpainALLUZIENCE 200 UNIDADES SPEYWOOD/ML SOLUCION INYECTABLEIpsen Pharma
- FranceALLUZIENCE 200 unités Speywood/mL, solution injectableIPSEN PHARMA
- IrelandAzzalure, 125 Speywood units, powder for solution for injectionIpsen Pharma
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Germany · Alluzience, Bocouture
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c2b4e39a-8573-4334-8237-99200ffc0659 GET /v1/drugs/c2b4e39a-8573-4334-8237-99200ffc0659?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAMUSCULAR",
"source": "ndc",
"strength": "300",
"substance": "BOTULINUM TOXIN TYPE A",
"productndc": "15054-0530",
"dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "U/1",
"application_number": "BLA125274",
"marketing_category": "BLA"
}See everything about botulinum toxin type a.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.